Safety and Pharmacokinetics of Halix(TM) Albuterol Unit Dose Disposable Inhaler Versus Albuterol MDI
Clinical trial NCT03373409 · COMPLETED
Trial details
- NCT number
- NCT03373409
- Sponsor
- Concentrx Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2018-05-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.